Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+13.66%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$14.8B
AUM Growth
+$2.81B
(+24%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
11.44%
Top 10 Holdings %
Top 10 Hldgs %
32.19%
Holding
1,185
New
65
Increased
729
Reduced
346
Closed
45
Top Buys
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$329M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$105M |
| 3 |
Texas Instruments
TXN
|
+$90.9M |
| 4 |
Tesla
TSLA
|
+$80.1M |
| 5 |
Intel
INTC
|
+$76M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$46.7M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$46.1M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$26.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$18.7M |
| 5 |
JPMorgan Chase
JPM
|
+$18.4M |
Sector Composition
| 1 | Technology | 42.09% |
| 2 | Financials | 11.46% |
| 3 | Healthcare | 8.37% |
| 4 | Energy | 5.47% |
| 5 | Consumer Discretionary | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
301
Madrigal Pharmaceuticals
MDGL
$9.59B
| $6.82M | 0.05% |
28,135
-77,255
| -73% | -$18.7M |
|
302
GE Aerospace
GE
$301B
| $6.8M | 0.05% |
89,120
-18,728
| -17% | -$1.43M |
|
|
HZNP
303
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.75M | 0.05% |
61,866
-21,019
| -25% | -$2.29M |
|
304
Vaxcyte
PCVX
$4.15B
| $6.74M | 0.05% |
179,881
-10,421
| -5% | -$391K |
|
305
Cytokinetics
CYTK
$6.22B
| $6.73M | 0.05% |
191,154
-34,223
| -15% | -$1.2M |
|
306
Sarepta Therapeutics
SRPT
$1.87B
| $6.7M | 0.05% |
48,646
-21,988
| -31% | -$3.03M |
|
307
Magnolia Oil & Gas
MGY
$4.5B
| $6.7M | 0.05% |
306,336
-30,711
| -9% | -$672K |
|
308
Iovance Biotherapeutics
IOVA
$876M
| $6.69M | 0.05% |
1,095,439
-70,259
| -6% | -$429K |
|
309
United Therapeutics
UTHR
$18.3B
| $6.67M | 0.05% |
29,791
+1,019
| +4% | +$228K |
|
310
Arrowhead Research
ARWR
$3.99B
| $6.67M | 0.05% |
262,431
-9,917
| -4% | -$252K |
|
311
Zscaler
ZS
$43.4B
| $6.6M | 0.04% |
56,511
+7,046
| +14% | +$823K |
|
312
Amicus Therapeutics
FOLD
$2.45B
| $6.6M | 0.04% |
594,701
-95,068
| -14% | -$1.05M |
|
313
Ironwood Pharmaceuticals
IRWD
$187M
| $6.55M | 0.04% |
622,175
-58,837
| -9% | -$619K |
|
314
CrowdStrike
CRWD
$109B
| $6.53M | 0.04% |
47,597
-2,738
| -5% | -$376K |
|
315
Twist Bioscience
TWST
$1.46B
| $6.5M | 0.04% |
431,068
+100,718
| +30% | +$1.52M |
|
316
Veracyte
VCYT
$2.42B
| $6.48M | 0.04% |
290,746
+9,018
| +3% | +$201K |
|
317
Beam Therapeutics
BEAM
$2.18B
| $6.48M | 0.04% |
211,668
+16,943
| +9% | +$519K |
|
318
TJX Companies
TJX
$156B
| $6.46M | 0.04% |
82,440
+6,841
| +9% | +$536K |
|
|
MRTX
319
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.45M | 0.04% |
173,516
-19,557
| -10% | -$727K |
|
320
Insmed
INSM
$30.8B
| $6.45M | 0.04% |
378,248
-58,554
| -13% | -$998K |
|
321
lululemon athletica
LULU
$19.7B
| $6.44M | 0.04% |
17,677
+3,828
| +28% | +$1.39M |
|
322
Palo Alto Networks
PANW
$133B
| $6.43M | 0.04% |
64,404
-5,940
| -8% | -$593K |
|
323
East-West Bancorp
EWBC
$15.1B
| $6.42M | 0.04% |
115,721
+84,157
| +267% | +$4.67M |
|
324
Boston Scientific
BSX
$155B
| $6.41M | 0.04% |
128,166
+4,932
| +4% | +$247K |
|
|
RXDX
325
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $6.38M | 0.04% |
59,464
-13,725
| -19% | -$1.47M |
|